FDA Drug Application (020364) for LOTREL by NOVARTIS

Back to FDA Applications sponsored by NOVARTIS

Application Number020364
Product Number002
FormCAPSULE;ORAL
DosageEQ 2.5MG BASE;10MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameLOTREL
Active IngredientAMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient AMLODIPINE BESYLATE21
List of drugs with Active Ingredient BENAZEPRIL HYDROCHLORIDE8


Back to FDA Applications sponsored by NOVARTIS